CERTARA INC. - COMMON STOCK

Certara Completes Acquisition of Pinnacle 21

04 Oct 2021 08:00:01 By Nasdaq GlobeNewswire

Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process

30 Sep 2021 16:30:00 By Nasdaq GlobeNewswire

Certara Announces New Clinical Science Group and Adds Senior Scientific Experts

22 Sep 2021 08:00:00 By Nasdaq GlobeNewswire

Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation

20 Sep 2021 08:00:01 By Nasdaq GlobeNewswire

Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

13 Sep 2021 16:30:00 By Nasdaq GlobeNewswire

Certara Announces Pricing of Public Offering of Common Stock

08 Sep 2021 21:00:57 By Nasdaq GlobeNewswire

Certara Announces Proposed Public Offering of Common Stock

03 Sep 2021 06:10:00 By Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

31 Aug 2021 16:30:00 By Nasdaq GlobeNewswire

Certara Reports Second Quarter 2021 Financial Results

05 Aug 2021 16:20:00 By Nasdaq GlobeNewswire

Certara to Acquire Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical Data

05 Aug 2021 16:15:00 By Nasdaq GlobeNewswire

Mubadala Invests in Global Biosimulation Leader Certara

27 Jul 2021 17:02:57 By Nasdaq GlobeNewswire

Certara’s Vaccine Simulator™ Accurately Predicted Optimal Timing Between Doses for COVID-19

23 Jul 2021 17:30:00 By Nasdaq GlobeNewswire

Certara Appoints Nancy Killefer and Cynthia Collins as New Independent Board Members

15 Jul 2021 16:30:00 By Nasdaq GlobeNewswire

Certara to Report Second Quarter 2021 Financial Results on August 5, 2021

14 Jul 2021 16:30:00 By Nasdaq GlobeNewswire

Certara Announces New Chief Human Resources Officer

13 Jul 2021 08:00:02 By Nasdaq GlobeNewswire

Certara Announces Update of BaseCase Software, the Company’s Value Communication Platform

08 Jul 2021 08:00:01 By Nasdaq GlobeNewswire

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions

23 Jun 2021 19:00:00 By Nasdaq GlobeNewswire

Certara Appoints Dr. Carol Gallagher as New Independent Board Member

14 Jun 2021 08:00:01 By Nasdaq GlobeNewswire

Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference

20 May 2021 08:00:01 By Nasdaq GlobeNewswire

Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies

13 May 2021 08:00:01 By Nasdaq GlobeNewswire